Suppr超能文献

腹膜透析人群中腹膜炎与心血管死亡率随时间的关联:一项澳大利亚和新西兰透析与移植登记研究

Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study.

作者信息

Cheikh Hassan Hicham I, Murali Karumathil, Lonergan Maureen, Boudville Neil, Johnson David, Borlace Monique, Chen Jenny H C

机构信息

Department of Renal Medicine, Wollongong Hospital, Wollongong, Australia.

Graduate School of Medicine, University of Wollongong, Wollongong, Australia.

出版信息

Kidney Int Rep. 2022 Aug 24;7(11):2388-2396. doi: 10.1016/j.ekir.2022.08.008. eCollection 2022 Nov.

Abstract

INTRODUCTION

Though peritonitis is associated with increased mortality in patients receiving peritoneal dialysis (PD), its association with cardiovascular mortality remains uncertain.

METHODS

The study participants included adult patients (≥18 years old) commencing PD in Australia (from October 2003 to December 2019) using the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry. Association between peritonitis and cardiovascular mortality was evaluated using Cox proportional hazards analysis and competing risks analysis. Associations between peritonitis rates between different eras and cardiovascular mortality were also compared using Jointpoint regression model to determine the time point when a significant change in peritonitis trend occurred to define the era for cardiovascular mortality. Subgroup analysis dividing the groups into 0, 1 and ≥2 episodes of peritonitis and sensitivity analysis censoring at 90 days post-transfer to hemodialysis (HD) were performed.

RESULTS

The study included 9699 incident PD patients. The overall peritonitis rate was 0.37 episodes per patient-year and declined by 4.7% (95% confidence interval [CI] 3.6-5.8%) during the study period. Peritonitis was associated with increased cardiovascular mortality risk (subdistribution hazard ratio [SHR] 1.53, 95% CI 1.39-1.69,  < 0.001) with increasing peritonitis episodes associated with higher risk (1 episode of peritonitis SHR 1.41, 95%CI 1.24-1.61; ≥2 episodes of peritonitis SHR 1.69, 95% CI 1.47-1.93,  < 0.001). Patients who commenced PD between 2012 and 2019 had a lower risk of cardiovascular mortality (SHR 0.60, 95% CI 0.50-0.72,  < 0.001), compared to patients who commenced between 2003 and 2011. Results were consistent in the sensitivity analysis.

CONCLUSION

Peritonitis is independently associated with an increased risk of cardiovascular mortality, and the association is episode-dependent. Prevention and adequate treatment of PD peritonitis may improve cardiovascular outcomes among patients receiving PD.

摘要

引言

尽管腹膜炎与接受腹膜透析(PD)的患者死亡率增加相关,但其与心血管死亡率的关联仍不确定。

方法

研究参与者包括在澳大利亚(2003年10月至2019年12月)开始进行PD的成年患者(≥18岁),使用澳大利亚和新西兰透析与移植(ANZDATA)登记处的数据。使用Cox比例风险分析和竞争风险分析评估腹膜炎与心血管死亡率之间的关联。还使用联合点回归模型比较不同时期腹膜炎发生率与心血管死亡率之间的关联,以确定腹膜炎趋势发生显著变化的时间点,从而定义心血管死亡率的时期。进行亚组分析,将患者分为腹膜炎发作0次、1次和≥2次的组,并进行敏感性分析,即在转至血液透析(HD)后90天进行删失。

结果

该研究纳入了9699例新发PD患者。总体腹膜炎发生率为每位患者每年0.37次发作,在研究期间下降了4.7%(95%置信区间[CI] 3.6 - 5.8%)。腹膜炎与心血管死亡风险增加相关(亚分布风险比[SHR] 1.53,95% CI 1.39 - 1.69,< 0.001),腹膜炎发作次数增加与更高风险相关(1次腹膜炎发作SHR 1.41,95% CI 1.24 - 1.61;≥2次腹膜炎发作SHR 1.69,95% CI 1.47 - 1.93,< 0.001)。与2003年至2011年开始进行PD的患者相比,2012年至2019年开始进行PD的患者心血管死亡风险较低(SHR 0.60,95% CI 0.50 - 0.72,< 0.001)。敏感性分析结果一致。

结论

腹膜炎与心血管死亡风险增加独立相关,且这种关联与发作次数有关。预防和充分治疗PD腹膜炎可能改善接受PD患者的心血管结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b6/9751840/fd96f2f8c5f0/fx1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验